These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 11427618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rapid blood flow short dialysis does not adversely affect clinical, biochemical, or nutritional status of patients.
    Rubin JE, Friedmann P, Berlyne GM.
    ASAIO Trans; 1986; 32(1):377-8. PubMed ID: 3778739
    [No Abstract] [Full Text] [Related]

  • 3. [Echocardiographic indices of uremia patients being treated by hemodiafiltration].
    Vinogradova TS, Filiptsev PIa, Kirkhman VV, Pronina VP, Timokhov VS.
    Sov Med; 1988; (12):103-6. PubMed ID: 3242105
    [No Abstract] [Full Text] [Related]

  • 4. Current trends in dialysis therapy.
    Jacobs C.
    Kidney Int Suppl; 1997 Nov; 62():S93-5. PubMed ID: 9350692
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The influence of larger molecules on cellular response in uremia.
    Giacchino F, Quarello F, Pozzato M, Giraudo G, Formica M, Quattrocchio G, Piccoli G.
    Trans Am Soc Artif Intern Organs; 1983 Nov; 29():29-32. PubMed ID: 6608816
    [No Abstract] [Full Text] [Related]

  • 7. Dialysis: Advances in Chronic Kidney Disease. Preface.
    Ronco C, Levin NW.
    Blood Purif; 2008 Nov; 26(1):5. PubMed ID: 18182787
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Calculation of the DMF index in a patient population with terminal uremia undergoing periodic hemodialysis].
    Calabrese L, Cervelli A, Taccone Gallucci M, Calabrese C, Tozzo C, Giorgetti G.
    Dent Cadmos; 1984 Oct; 52(10 Suppl):89, 92-3. PubMed ID: 6598774
    [No Abstract] [Full Text] [Related]

  • 13. Phagocytic function in the uremic patient.
    Ringoir S, Vanholder R.
    Contrib Nephrol; 1992 Oct; 100():15-24. PubMed ID: 1458900
    [No Abstract] [Full Text] [Related]

  • 14. Uremia Retention Molecules and Clinical Outcomes.
    Barreto FC, Barreto DV, Canziani MEF.
    Contrib Nephrol; 2017 Oct; 191():18-31. PubMed ID: 28910788
    [Abstract] [Full Text] [Related]

  • 15. [Thyroid function in chronic uremia patients undergoing periodic hemodialysis treatment].
    Naso A, Gasparotto ML, Girelli ME, Zanatta GP, Bertoli M, Cerutti M, Di Landro D, Romagnoli GF.
    Minerva Nefrol; 1980 Oct; 27(3):403-8. PubMed ID: 6785673
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Continuous intestinal dialysis for uraemia by intermittent oral intake of non-absorbable solutions. An experimental study.
    Miskowiak J.
    Scand J Urol Nephrol; 1991 Oct; 25(1):71-4. PubMed ID: 1904625
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of hyperhydrated states by means of hemofiltration].
    Levitskiĭ ER, Baeva LB, Dmitriev AA, Volkova NA, Salagaeva AB.
    Sov Med; 1978 Oct; (10):65-8. PubMed ID: 715538
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of terminal-stage uremia by substitution dialysis methods in France in December 1981].
    Jacobs C, Patte R.
    Nephrologie; 1983 Oct; 4(2):64-8. PubMed ID: 6877480
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.